Name : Mr.

RISHI JAIN
Lab No. : 465613943 Age : 20 Years
Ref By : SELF Gender : Male
Collected : 04/8/2024 11:05:00AM Reported : 05/8/2024 3:43:54PM
A/c Status : P Report Status : Final
Collected at : PSC JAYANAGAR 2 Processed at : LPL-BENGALURU REFERENCE LAB
1115, 26th B Main, 41st Cross, Jayanagar, 9th NO.17/1,SERVICE ROAD, THE
Block ADDRESS,OPP PRESTIGE CESSNA PARK,
BANGALORE OUTER RING ROAD ,KADUBEESANAHALLI
,BANGALORE-560103

Test Report

Test Name Results Units Bio. Ref. Interval

SwasthFit Super 4

LIVER & KIDNEY PANEL, SERUM

BUN/Creatinine Ratio

7.80

75.0

Page 1 of 10
Name : Mr. RISHI JAIN
Lab No. : 465613943 Age : 20 Years
Ref By : SELF Gender : Male
Collected : 04/8/2024 11:05:00AM Reported : 05/8/2024 3:43:54PM
A/c Status : P Report Status : Final
Collected at : PSC JAYANAGAR 2 Processed at : LPL-BENGALURU REFERENCE LAB
1115, 26th B Main, 41st Cross, Jayanagar, 9th NO.17/1,SERVICE ROAD, THE
Block ADDRESS,OPP PRESTIGE CESSNA PARK,
BANGALORE OUTER RING ROAD ,KADUBEESANAHALLI
,BANGALORE-560103

Test Report

Test Name Results Units Bio. Ref. Interval

Sodium

Potassium

Page 2 of 10
Name : Mr. RISHI JAIN
Lab No. : 465613943 Age : 20 Years
Ref By : SELF Gender : Male
Collected : 04/8/202411:05:00AM Reported : 05/8/2024 3:43:54PM
A/c Status : P Report Status : Final
Collected at : PSC JAYANAGAR 2 Processed at : LPL-BENGALURU REFERENCE LAB
1115, 26th B Main, 41st Cross, Jayanagar, 9th NO.17/1,SERVICE ROAD, THE
Block ADDRESS,OPP PRESTIGE CESSNA PARK,
BANGALORE OUTER RING ROAD ,KADUBEESANAHALLI
,BANGALORE-560103

Test Report

Test Name Results Units Bio. Ref. Interval

LIPID SCREEN, SERUM

(CHO-POD)

Cholesterol, Total 157.00 mg/dL <200.00

Triglycerides 121.00 mg/dL <150.00

HDL Cholesterol 41.00 mg/dL >40.00

LDL Cholesterol, Calculated 98.80 mg/dL <100.00

VLDL Cholesterol,Calculated 24.20 mg/dL <30.00

Non-HDL Cholesterol 123 mg/dL <130

Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. Additional testing for Apolipoprotein B, hsCRP, Lp(a ) & LP-PLA2 should be considered
among patients with moderate risk for ASCVD for risk refinement.

Treatment Goals as per Lipid Association of India 2020

| RISK | TREATMENT GOAL | CONSIDER THERAPY |

| CATEGORY |-----------------------------------------|------------------------------------------------------------------------ |
| | LDL CHOLESTEROL | NON HDL CHLOESTEROL| LDL CHOLESTEROL| NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)|
|------------|--------------------|--------------------|----------------| ------------------------------------------ |
| Extreme | <50 | <80 | | |
| Risk Group |(Optional goal ≤30) |(Optional goal ≤60) | ≥50 | ≥80 |
| Category A | | | | |
|------------|--------------------|--------------------|----------------| ------------------------------------------ |
| Extreme | | | | |
| Risk Group | ≤30 | ≤60 | >30 | >60 |
| Category B | | | | |
|------------|--------------------|--------------------|----------------| ------------------------------------------ |
| Very | <50 | <80 | ≥50 | ≥80 |
| High | | | | |
|------------|--------------------|--------------------|----------------| ------------------------------------------ |
| High | <70 | <100 | ≥70 | ≥100 |
|------------|--------------------|--------------------|----------------| ------------------------------------------ |
| Moderate | <100 | <130 | ≥100 | ≥130 |
|------------|--------------------|--------------------|----------------| ------------------------------------------ |
| Low | <100 | <130 | ≥130* | ≥160* |

*In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months

Page 3 of 10
Name : Mr. RISHI JAIN
Lab No. : 465613943 Age : 20 Years
Ref By : SELF Gender : Male
Collected : 04/8/2024 11:05:00AM Reported : 05/8/2024 3:43:54PM
A/c Status : P Report Status : Final
Collected at : PSC JAYANAGAR 2 Processed at : LPL-BENGALURU REFERENCE LAB
1115, 26th B Main, 41st Cross, Jayanagar, 9th NO.17/1,SERVICE ROAD, THE
Block ADDRESS,OPP PRESTIGE CESSNA PARK,
BANGALORE OUTER RING ROAD ,KADUBEESANAHALLI
,BANGALORE-560103

Test Report

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F)

VITAMIN B12; CYANOCOBALAMIN

90.00

Interpretation
| Remarks | Result In pg/mL |
|----------------| ------------------------------------------------- |
| Normal | 180 - 914 |
|----------------| ------------------------------------------------- |
| Indeterminate | 120 - 180 |
|----------------| ------------------------------------------------- |
| Deficient | < 120 |

Notes
1. Interpretation of the result should be considered in relation to clinical circumstances.
2. It is recommended to consider supplementary testing with plasma Methylmalonic acid (MMA) or
plasma homocysteine levels to determine biochemical cobalamin deficiency in presence of clinical
suspicion of deficiency but indeterminate levels. Homocysteine levels are more sensitive but MMA is
more specific

3. False increase in Vitamin B12 levels may be observed in patients with intrinsic factor blocking
antibodies, MMA measurement should be considered in such patients

4. The concentration of Vitamin B12 obtained with different assay methods cannot be used
interchangeably due to differences in assay methods and reagent specificity

VITAMIN D, 25 - HYDROXY, SERUM

34.13

Interpretation

Page 4 of 10
Name : Mr. RISHI JAIN
Lab No. : 465613943 Age : 20 Years
Ref By : SELF Gender : Male
Collected : 04/8/2024 11:05:00AM Reported : 05/8/2024 3:43:54PM
A/c Status : P Report Status : Final
Collected at : PSC JAYANAGAR 2 Processed at : LPL-BENGALURU REFERENCE LAB
1115, 26th B Main, 41st Cross, Jayanagar, 9th NO.17/1,SERVICE ROAD, THE
Block ADDRESS,OPP PRESTIGE CESSNA PARK,
BANGALORE OUTER RING ROAD ,KADUBEESANAHALLI
,BANGALORE-560103

Test Report

Test Name Results Units Bio. Ref. Interval

| LEVEL | REFERENCE RANGE IN nmol/L| COMMENTS |
|---------------|--------------------------| ---------------------------------------------------------------------------------------------- |
| Deficient | < 50 | High risk for developing bone disease |
|---------------|--------------------------| ---------------------------------------------------------------------------------------------- |
| Insufficient | 50-74 | Vitamin D concentration which normalizes |
| | | Parathyroid hormone concentration |
|---------------|--------------------------| ---------------------------------------------------------------------------------------------- |
| Sufficient | 75-250 | Optimal concentration for maximal health benefit|
|---------------|--------------------------| ---------------------------------------------------------------------------------------------- |
| Potential | >250 | High risk for toxic effects |
| intoxication | | |

Note
• The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.
• 25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.
• Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.
• It shows seasonal variation, with values being 40-50% lower in winter than in summer.
• Levels vary with age and are increased in pregnancy.
• A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available

THYROID PROFILE,TOTAL, SERUM

(CLIA)

T3, Total 1.06 ng/mL 0.70 - 2.04

T4, Total 6.67 µg/dL 5.74 - 13.03

TSH 2.01 µIU/mL 0.34 - 5.60

Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations.
2. Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or
Total T4 levels especially in pregnancy and in patients on steroid therapy.
3. Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate
more closely with clinical status of the patient than total T4/T3 concentration
4. Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals
Page 5 of 10
Name : Mr. RISHI JAIN
Lab No. : 465613943 Age : 20 Years
Ref By : SELF Gender : Male
Collected : 04/8/2024 11:05:00AM Reported : 05/8/2024 3:43:54PM
A/c Status : P Report Status : Final
Collected at : PSC JAYANAGAR 2 Processed at : LPL-BENGALURU REFERENCE LAB
1115, 26th B Main, 41st Cross, Jayanagar, 9th NO.17/1,SERVICE ROAD, THE
Block ADDRESS,OPP PRESTIGE CESSNA PARK,
BANGALORE OUTER RING ROAD ,KADUBEESANAHALLI
,BANGALORE-560103

Test Report

Test Name Results Units Bio. Ref. Interval

Page 6 of 10
Name : Mr. RISHI JAIN
Lab No. : 465613943 Age : 20 Years
Ref By : SELF Gender : Male
Collected : 04/8/2024 11:05:00AM Reported : 05/8/2024 3:43:54PM
A/c Status : P Report Status : Final
Collected at : PSC JAYANAGAR 2 Processed at : LPL-BENGALURU REFERENCE LAB
1115, 26th B Main, 41st Cross, Jayanagar, 9th NO.17/1,SERVICE ROAD, THE
Block ADDRESS,OPP PRESTIGE CESSNA PARK,
BANGALORE OUTER RING ROAD ,KADUBEESANAHALLI
,BANGALORE-560103

Test Report

Test Name Results Units Bio. Ref. Interval

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD

Interpretation
HbA1c result is suggestive of non diabetic adults (>=18 years)/ well controlled Diabetes in a known Diabetic
Interpretation as per American Diabetes Association (ADA) Guidelines

| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |

| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |
| ----------------|-------------------|---------------|-------------| ---------------------------------------- |
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.

| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |

| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|---------------------------------------------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |

Page 7 of 10
Name : Mr. RISHI JAIN
Lab No. : 465613943 Age : 20 Years
Ref By : SELF Gender : Male
Collected : 04/8/2024 11:05:00AM Reported : 05/8/2024 3:43:54PM
A/c Status : P Report Status : Final
Collected at : PSC JAYANAGAR 2 Processed at : LPL-BENGALURU REFERENCE LAB
1115, 26th B Main, 41st Cross, Jayanagar, 9th NO.17/1,SERVICE ROAD, THE ADDRESS,O
Block PRESTIGE CESSNA PARK, OUTER RING R
BANGALORE ,KADUBEESANAHALLI ,BANGALORE-5601

Test Report

Test Name Results Units Bio. Ref. Interval

COMPLETE BLOOD COUNT; CBC

(Flow Cytometery, SLS)

Hemoglobin 15.60 g/dL 13.00 - 17.00

Packed Cell Volume (PCV) 49.30 % 40.00 - 50.00

RBC Count 5.54 mill/mm3 4.50 - 5.50

MCV 89.00 fL 83.00 - 101.00

Mentzer Index 16.1

MCH 28.20 pg 27.00 - 32.00

MCHC 31.60 g/dL 31.50 - 34.50

Red Cell Distribution Width (RDW) 12.00 % 11.60 - 14.00

Total Leukocyte Count (TLC) 10.11 thou/mm3 4.00 - 10.00

Differential Leucocyte Count (DLC)

Segmented Neutrophils 62.20 % 40.00 - 80.00

Lymphocytes 26.80 % 20.00 - 40.00

Monocytes 6.80 % 2.00 - 10.00

Eosinophils 3.30 % 1.00 - 6.00

Basophils 0.90 % <2.00

Absolute Leucocyte Count

Neutrophils 6.29 thou/mm3 2.00 - 7.00

Lymphocytes 2.71 thou/mm3 1.00 - 3.00

Monocytes 0.69 thou/mm3 0.20 - 1.00

Eosinophils 0.33 thou/mm3 0.02 - 0.50

Page 8 of 10
Name : Mr. RISHI JAIN
Lab No. : 465613943 Age : 20 Years
Ref By : SELF Gender : Male
Collected : 04/8/2024 11:05:00AM Reported : 05/8/2024 3:43:54PM
A/c Status : P Report Status : Final
Collected at : PSC JAYANAGAR 2 Processed at : LPL-BENGALURU REFERENCE LAB
1115, 26th B Main, 41st Cross, Jayanagar, 9th NO.17/1,SERVICE ROAD, THE ADDRESS,O
Block PRESTIGE CESSNA PARK, OUTER RING R
BANGALORE ,KADUBEESANAHALLI ,BANGALORE-5601

Test Report

Test Name Results Units Bio. Ref. Interval

Basophils 0.09 thou/mm3 0.02 - 0.10

Platelet Count 427 thou/mm3 150.00 - 410.00

Mean Platelet Volume 8.4 fL 6.5 - 12.0

Comment
In anaemic conditions Mentzer index is used to differentiate Iron Deficiency Anaemia from Beta- Thalassemia
trait. If Mentzer Index value is >13, there is probability of Iron Deficiency Anaemia. A value < 13 indicates likelihood
of Beta- Thalassemia trait and Hb HPLC is advised to rule out the Thalassemia trait.

Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood

Dr Awantika Tiwari DR HARISH K Dr. Sajith K Satheesh Dr.Swetha V

MD, Pathology MBBS,DCP MD, PDCC (Oncopathology) MD, Biochemistry
Consultant Pathologist Chief of Laboratory Sr. Consultant Pathologist Senior Consultant - Clinical Chemistry
Dr Lal PathLabs Ltd & Biochemical Genetics
Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

Page 9 of 10
Name : Mr. RISHI JAIN
Lab No. : 465613943 Age : 20 Years
Ref By : SELF Gender : Male
Collected : 04/8/2024 11:05:00AM Reported : 05/8/2024 3:43:54PM
A/c Status : P Report Status : Final
Collected at : PSC JAYANAGAR 2 Processed at : LPL-BENGALURU REFERENCE LAB
1115, 26th B Main, 41st Cross, Jayanagar, 9th NO.17/1,SERVICE ROAD, THE ADDRESS,O
Block PRESTIGE CESSNA PARK, OUTER RING R
BANGALORE ,KADUBEESANAHALLI ,BANGALORE-5601

Test Report

Test Name Results Units Bio. Ref. Interval

IMPORTANT INSTRUCTIONS
 Test results released pertain to the specimen submitted .All test results are dependent on the quality of the sample received by the Laboratory .
 Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .Report
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .Certain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.Test results may show interlaboratory variations .The
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).Test results are not valid
for medico legal purposes.This is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor.The report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com

Page 10 of 10